APT(SH:688617) Sou Hu Cai Jing·2025-06-07 05:27Core Viewpoint - Huatai Medical (688617) has announced adjustments to its 2024 profit distribution plan, including cash dividends and capital reserve share increases, following the completion of the third vesting period of its 2021 restricted stock incentive plan [1][2]. Company Announcements - Huatai Medical will distribute a cash dividend of RMB 17.50 per 10 shares (including tax) and will increase its share capital by 4.5 shares for every 10 shares held, resulting in a total cash distribution of RMB 170,189,064.50 (including tax) and an increase of 43,762,902 shares in capital reserve [1][2]. - The total number of shares will increase from 97,081,956 to 141,013,796 after the adjustments [1]. - The completion of the third vesting period of the restricted stock incentive plan resulted in the listing of 168,938 shares, with the total share capital increasing from 97,081,956 to 97,250,894 shares [2]. - The controlling shareholder and actual controller of the company remain unchanged after the stock changes [2]. - CITIC Securities conducted a compliance inspection of Huatai Medical's operations from January 1, 2024, to the date of the inspection, confirming that the company meets the requirements set by the China Securities Regulatory Commission and the Shanghai Stock Exchange [2].